Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quality-adjusted life years.

Yolanda Bravo Vergel1, Mark Sculpher

  • 1Centre for Health Economics, University of York, York, UK.

Practical Neurology
|May 27, 2008
PubMed
Summary
This summary is machine-generated.

Health systems use cost-effectiveness analysis to fund interventions. The quality-adjusted life-year (QALY) measures health outcomes, reflecting quality of life and life expectancy changes, aiding funding decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trial.

Contemporary clinical trials·2026
Same author

What is the Value of Developing an HTA Process?

PharmacoEconomics·2026
Same author

Modelling the cost-effectiveness of interventions to treat or prevent neuropathic ulcers arising from leprosy: application to L-PRF.

Cost effectiveness and resource allocation : C/E·2026
Same author

Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and Eradication.

Applied health economics and health policy·2026
Same author

Alternative Pricing Policies for Multi-Indication Products: A Quantitative Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Reply to "On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation".

Clinical pharmacology and therapeutics·2026
Same journal

Who I am affects what I do.

Practical neurology·2026
Same journal

Recurrent falls while taking clozapine.

Practical neurology·2026
Same journal

Anti-Ma2 encephalitis: when the examination localises beyond MRI.

Practical neurology·2026
Same journal

Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care.

Practical neurology·2026
Same journal

Neurological signs of possible diagnostic value in the cognitive clinic: past, present and future.

Practical neurology·2026
Same journal

Longitudinally extensive myelitis in neurosarcoidosis.

Practical neurology·2026
See all related articles

Area of Science:

  • Health Economics
  • Outcomes Research

Background:

  • Health systems increasingly utilize cost-effectiveness analysis for resource allocation.
  • Accurate measurement of health outcomes is crucial for informed funding decisions.

Purpose of the Study:

  • To describe the concept of the quality-adjusted life-year (QALY).
  • To explain the derivation of QALYs.
  • To discuss the strengths and weaknesses of QALYs in health measurement.

Main Methods:

  • Conceptual explanation of QALYs.
  • Review of QALY derivation methodologies.
  • Analysis of QALY strengths and limitations.

Main Results:

  • QALYs integrate health-related quality of life and life expectancy into a single metric.

Related Experiment Videos

  • The derivation involves assigning utility values to health states.
  • QALYs are widely used but have limitations in capturing all aspects of health outcomes.

    • Conclusions:

    • QALYs are a central tool for health measurement in cost-effectiveness analysis.
    • Understanding QALYs' derivation, strengths, and weaknesses is essential for decision-makers.
    • QALYs facilitate comparisons across diverse health interventions.